PUBLISHER: The Business Research Company | PRODUCT CODE: 1946623
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946623
A non-invasive cholesterol reader is a medical device or diagnostic tool used to measure cholesterol levels in the body without the need for blood samples or needles. These devices commonly utilize technologies such as optical sensors, spectroscopy, or electromagnetic waves to detect cholesterol through the skin or other external methods.
The primary product types of non-invasive cholesterol readers include wearable devices, handheld devices, and tabletop devices. Wearable devices are small, body-mounted instruments such as patches, bands, or wristbands that collect physiological data continuously or at regular intervals with minimal discomfort. These devices operate using technologies such as optical, ultrasound, electrical, and others. They are distributed through both online and offline channels and are used across various applications, including home care, hospitals and clinics, diagnostic centers, and other healthcare settings.
Tariffs are impacting the non-invasive cholesterol reader market by increasing the cost of imported optical sensors, electronics, and handheld device components, particularly affecting wearable and portable readers manufactured in China and Southeast Asia. These tariffs have raised retail prices in North America and Europe, slowing adoption, but have also encouraged local manufacturing, supply chain diversification, and innovation in cost-efficient devices.
The non-invasive cholesterol reader market research report is one of a series of new reports from The Business Research Company that provides non-invasive cholesterol reader market statistics, including non-invasive cholesterol reader industry global market size, regional shares, competitors with a non-invasive cholesterol reader market share, detailed non-invasive cholesterol reader market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive cholesterol reader industry. This non-invasive cholesterol reader market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The non-invasive cholesterol reader market size has grown rapidly in recent years. It will grow from $1.3 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to rising cardiovascular disease prevalence, growing awareness of cholesterol monitoring, demand for non-invasive diagnostics, adoption in homecare settings, technological improvements in optical sensors.
The non-invasive cholesterol reader market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to AI-enabled diagnostics, integration with telemedicine, miniaturization of devices, expansion in emerging markets, continuous real-time monitoring. Major trends in the forecast period include optical sensor-based devices, wearable cholesterol monitoring, portable diagnostic devices, integration with mobile health apps, home-based cholesterol testing.
The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the non-invasive cholesterol reader market in the coming years. Cardiovascular diseases, including coronary artery disease, stroke, and heart failure, are becoming increasingly common due to aging populations and sedentary lifestyles that elevate the risk of heart and vascular complications. Non-invasive cholesterol readers play a crucial role in early detection by enabling quick cholesterol measurements without the need for blood samples, supporting timely interventions to reduce the risk of heart attacks and strokes. For example, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, cardiovascular diseases caused 919,032 deaths in 2023, accounting for nearly one-third of all deaths. Hence, the growing incidence of cardiovascular diseases is contributing significantly to the expansion of the non-invasive cholesterol reader market.
The rise in healthcare expenditure is expected to boost the growth of the non-invasive cholesterol reader market. Healthcare expenditure encompasses total spending on medical services, treatments, and health-related goods aimed at improving population health. The steady increase in healthcare spending is primarily driven by the growing burden of chronic diseases, which demand ongoing care and management. Higher investment in healthcare facilitates the development and adoption of non-invasive diagnostic technologies that enable early cholesterol monitoring and reduce dependence on invasive procedures and costly hospital visits. For instance, according to the Office for National Statistics (ONS), a U.K.-based government agency, public healthcare spending in the United Kingdom reached $346 billion (£258 billion) in 2024, marking a 2.5% increase in real terms compared to 2023. Therefore, the rising healthcare expenditure is playing a pivotal role in driving demand for non-invasive cholesterol readers.
In August 2024, the National University of Singapore (NUS) collaborated with the Agency for Science, Technology and Research (ASTAR) to develop a non-invasive sensor capable of detecting cholesterol and glucose levels through the skin. The partnership aims to design and commercialize a wearable hydrogel-based sensor for continuous, real-time, and non-invasive monitoring of biomarkers such as cholesterol and glucose on dry skin. This innovation is expected to enhance early disease detection, chronic disease management, and remote health monitoring. ASTAR, a Singapore-based public research agency focused on economic-driven innovation, is actively contributing to the advancement of non-invasive cholesterol reader technologies.
Major companies operating in the non-invasive cholesterol reader market are SiPhox Health Inc., Binah.ai Ltd., Occuity Ltd., PreVu Inc., CardioDiagnostics Inc., Scanadu Inc., Aidar Health Inc., Biovotion AG, Valencell Inc., Rockley Photonics Inc., LifeQ B.V., ChroniSense Medical Ltd., EchoLabs AI Inc., Grove Instruments LLC, MediBioSense Health Care, VitalConnect Inc., Sensible Medical Innovations Ltd., Current Health Ltd., Empatica Inc., BioIntelliSense Inc.
North America was the largest region in the non-invasive cholesterol reader market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-invasive cholesterol reader market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the non-invasive cholesterol reader market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The non-invasive cholesterol reader market consists of sales of non-invasive skin cholesterol detection system, stretchable hydrogel-based wearable sensor, and cholesterol monitor. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Non-Invasive Cholesterol Reader Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses non-invasive cholesterol reader market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for non-invasive cholesterol reader ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-invasive cholesterol reader market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.